J.Henderson Gl.Life Sciences F.A2 H/  IE00BFTCP959  /

Fonds
NAV2/16/2024 Chg.+0.1600 Type of yield Investment Focus Investment company
24.6800CNH +0.65% reinvestment Equity Worldwide Janus Henderson Inv. 
 

Investment goal

The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Health / Pharma
Benchmark: MSCI World Healthcare Index
Business year start: 1/1
Last Distribution: -
Depository bank: J.P. Morgan SE Dublin Branch
Fund domicile: Ireland
Distribution permission: Austria, Germany, Switzerland
Fund manager: Andy Acker, Daniel Lyons
Fund volume: 3.97 bill.  USD
Launch date: 10/3/2014
Investment focus: -

Conditions

Issue surcharge: 5.00%
Max. Administration Fee: 1.50%
Minimum investment: 15,000.00 CNH
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Janus Henderson Inv.
Address: 201 Bishopsgate, EC2M 3AE, London
Country: United Kingdom
Internet: www.janushenderson.com/
 

Assets

Stocks
 
99.68%
Cash
 
0.30%
Others
 
0.02%

Countries

United States of America
 
72.60%
Denmark
 
5.68%
United Kingdom
 
4.45%
Switzerland
 
3.88%
France
 
2.67%
Ireland
 
2.45%
Japan
 
1.55%
Netherlands
 
1.50%
China
 
1.18%
Virgin Islands (British)
 
0.97%
Cash
 
0.30%
Cayman Islands
 
0.27%
Canada
 
0.25%
Others
 
2.25%

Branches

Pharma/Biotechnology
 
60.53%
Healthcare appliances
 
17.80%
Healthcare services
 
17.70%
Parma, wholesale
 
1.42%
Cash
 
0.30%
Others
 
2.25%